We recruited 1255 lipid-lowering drug-naïve subjects with normal fasting glucose (NFG; n = 200, 15.9%), impaired fasting glucose (IFG; n = 443, 35.3%), or type 2 diabetes (T2D; n = 612, 48.8%). Lipoprotein subfractions (1–7) were determined by polyacrylamide gel electrophoresis, separating low-density lipoprotein (LDL) into large buoyant LDL (lbLDL, LDL1–2) and small dense LDL (sdLDL, LDL3–7). Lipoprotein subfraction parameters including the sdLDL% (LDL3–7/LDL1–7), the sdLDL/lbLDL ratio (LDL3–7/LDL1–2), and weighted LDL subfraction (LDLSF) scores, were compared between groups. Their associations with insulin resistance, estimated using the homeostasis model assessment of insulin resistance, were examined.
The concentrations of sdLDL particles were significantly higher in subjects with T2D and IFG than in those with NFG (15.78 ± 13.47 mg/dl and 14.60 ± 14.33 mg/dl, respectively, vs. 12.22 ± 12.31 mg/dl). Compared with those with NFG, subjects with IFG or T2D had significantly a higher sdLDL% (15.98 ± 15.26% vs. 19.50 ± 16.21% or 21.46 ± 16.81%, respectively), a higher sdLDL/lbLDL ratio (0.24 ± 0.30 vs. 0.31 ± 0.37 or 0.35 ± 0.39), and a higher LDLSF score (2.08 ± 0.91 vs. 2.30 ± 1.14 or 2.36 ± 1.17). These lipoprotein subfraction parameters had stronger associations with insulin resistance compared to conventional lipid profiles in the IFG and T2D groups.
Atherogenic dyslipidemia is initiated in an early stage of impaired glucose metabolism, when early intervention might be required.